Synapticure

Look forward to seeing everyone shortly to meet with ALS patients who in @Neuralink's BCI study and learn how they're using it to today.

Register here to join or receive the video. vist.ly/4b2p8

BCI has the chance to restore the little things we take for granted as healthy adults every day -- communication, moving a mouse, and hopefully someday replacing lost control of movement. We're grateful for the chance to build awareness for these and other programs in ALS.

Click the link above to register and connect with patients who are using Neuralink today to hear about their journey to BCI, their decision to join the trial, and how it has changed their lives. Please feel free to submit questions in advance in the registration link.

Brain Computer Interfaces (BCI) has the chance to dramatically change care for ALS patients. We are grateful to host three patients in Neuralink's ALS trial for webinar on October 28th at 2PM ET with representatives from @neuralink.

register here: vist.ly/4bhnb

Synapticure is excited to share that we will be hosting a webinar on October 28, 2025 with participants in the @Neuralink ongoing ALS trial, along with representatives from the company.

The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS

Exciting news! Our CEO, Sandra Abrevaya, will keynote at New York Brain-Computer Interface Symposium (#NYBCI25) in NYC (Oct 3-4) on the power of advocacy in #BCI innovation.

From virtual visits with leading specialists to wraparound care, medication management, genetic testing, counseling, and access to clinical trials— we make expert care available all from the comfort of your home.

Learn more at synapticure.com

#ALZ #ALS #PD

Curious about genetic testing? You’re not alone.

Read our experts' insights on our blog.

Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.

#GeneticTesting #ClinicalTrials #Genetics

Synapticure’s Origin Story: Our Mission, Milestones, and Impact | Synapticure After an ALS diagnosis at 37, Brian Wallach and Sandra Abrevaya founded Synapticure to fix a broken system. Learn how their personal story became a national model for virtual neurodegenerative care.

From one family’s journey to a national movement— our latest blog shares the story behind our mission and the care model we've built to support millions of families across country.

Read the full story here → vist.ly/446ui

#Alzheimers #ALS #Parkinsons #Dementia

At the @alsassociation #ALSNexus, we were proud to highlight caregivers’ vital role in #ALSCare + share our fully remote #ClinicalTrial for #ALS. We're proud to stand with a community that won’t give up on better care, better treatments, and a better future.

Did you know that addressing mental health is a crucial, yet often unmet, need for those facing #neurodisorders? Our CoCM program ensures that emotional well-being is a core component of care.

Because true support is more than just treating symptoms 💙

vist.ly/43ry7

10,000 psychologists. One massive conference. And Synapticure on stage.

Last week Dr. Meyers shared our CoCM data at the @APA Annual Conference— showing how we improve quality of life + reduce depression & anxiety for people living with #neurodiseases.

Meet Dr. Tate, a fellowship-trained movement disorder specialist! She's passionate about patient-centered care, shared decision-making, and in-home neurology care, especially for people living in rural areas (growing up in a rural area herself!)

Learn more vist.ly/32cn8

Mark your calendars! Chief Medical Officer Dr. Eric Anderson is speaking at @alsassociation #ALSNexus conference, joining a powerful conversation on one of the most over-looked forces in #ALS care: family caregivers.

Learn more: vist.ly/328qz

#Caregivers

What do you get when you mix bold ideas, neuroscience, and a whole lot of brainpower? A week at #AAIC with our team 😄🧠

We had a blast sharing our work and learning from so many others pushing the boundaries in #Alzheimer’s research and care delivery.

“I had no knowledge about Alzheimer's or dementia.” Like many caregivers, Sherry felt overwhelmed—until she connected with our expert team through Senior Helpers.

You don’t need to be an expert. You just need a care partner who is

Learn more at synapticure.com or (855) 255-5917

The ALS Association Awards 8 Hoffman ALS Clinic Development & Capacity Awards to Expand Access to Life-Enhancing Multidisciplinary ALS Care /PRNewswire/ -- The ALS Association announced inaugural recipients of the Hoffman ALS Clinic Development and Capacity Awards, new grant programs established to...

We’re thrilled to share that Synapticure was awarded the Hoffman ALS Clinic Capacity Award by the @alsassociation to expand access to expert, multidisciplinary ALS care through telemedicine.

Read the release: vist.ly/3zkur


#EndALS #ALSCare #Telehealth #VirtualCare

🧵 A new study shows that dogs may be able to sniff out Parkinson’s disease— even before symptoms appear.

vist.ly/3zg34

This breakthrough could open new doors for early detection and intervention.

#Parkinsons #PD #Research #PDNews

What’s the difference between #Alzheimer’s and #dementia? 🧠 It’s not just semantics—understanding the difference can lead to better care and earlier support.

Looking for support? Visit synapticure.com or call (855) 255-5917


#AlzheimersAwareness

If you're building something in #neurodegeneration, let's build it together, with patient-derived platforms that bring you closer to clinical relevance.

Let’s make a difference together ➡️ https://www.synapticure.com/for-partners/research


#partnering #biotech #drugdiscovery

🤝 Our work is built to accelerate yours. Whether you're testing a therapeutic hypothesis, running phenotypic screens, or developing patient-relevant models, our team supports:

✔ Target discovery and validation
✔ Compound screening
✔ Model customization

Ozzy Osbourne’s Death Puts Spotlight on Parkinson’s Disease Ozzy Osbourne, lead singer of Black Sabbath, has died at age 76. He said he had been previously diagnosed with a form of Parkinson’s disease linked to the gene PRKN

Ozzy Osbourne wasn’t just the Prince of Darkness— he was a global icon who helped shine a light on the reality of #Parkinsons

As we honor his legacy, we’re reminded of the millions living with #PD and the urgent need for expert care & continued research

vist.ly/3yxi6

A routine appointment. A life-altering diagnosis. Six months to live. This was co-founders Sandra Abrevaya and Brian Wallach's reality, and it ignited their fight for change- So no one faces #ALS, #ALZ, #PD, #HD or related conditions alone.

Learn more ➡️ vist.ly/3yec3

Learn more about our study here https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900015-2 or visit

🔍 To learn more about our research visit https://www.synapticure.com/for-partners/research

#precisionmedicine #neurodegeneration #biomarkers

This allows us to ask meaningful questions about how cellular phenotypes map back to clinical trajectories.

💡It’s one way we’re trying to make preclinical data more clinically relevant from the start.

combining cutting edge 3D Cortical Brain Spheroids developed in our labs with our nationwide careND platform providing access to metadata such as genetics and phenotypes that can be correlated with the observations from the lab...

🧬 The value of our in vitro models lies on how closely they reflect patient biology.

Our unique strength lies in...

Ever left a doctor’s appointment feeling rushed, confused, or like your concerns didn’t matter?

Not here. You deserve care that’s thorough, personal, and makes you feel heard 💙

Visit synapticure.com or call (855) 255-5917 to learn more

Celebrating the 4th of July while caring for someone with dementia? Here are 5 tips from our experts to help you navigate the day with calm, comfort, and connection 💙


#Dementia #DementiaTips #CaregiverTips #DementiaCaregiver #Alzheimers #CaregiverResources #IndependenceDay #FourthofJuly

This model enables identification of new mechanisms of disease, creating a tool to identify new drug targets, design & develop clinical trials, & accelerate the development of personalized therapies.

Learn more at lab@synapticure.com or https://www.synapticure.com/for-partners/research